Company
Voyager Therapeutics, Inc. (VYGR)
Standardized SEC financial data for Voyager Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001640266 · NASDAQ · Biological Products, (No Diagnostic Substances).
Operating margin
-326.6%
Net margin
-296.5%
Revenue growth (YoY)
-49.5%
Return on equity
-61.1%
Free cash flow
-$135.1M
Current ratio
7.64×
EPS (diluted)
$-2.04
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $171.1M | $37.4M | $40.9M | $250.0M | $80.0M | $40.4M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $106.2M | $119.2M | $118.8M | $230.9M | $332.4M | $201.7M |
| Accounts receivable |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$96.7M | -$53.5M | -$12.5M | $77.9M | -$15.3M | -$132.5M |
| Capital expenditures |
Get VYGR data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/VYGR/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/VYGR/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"